diethylstilbestrol 5mg tablets
alliance healthcare (distribution) ltd - diethylstilbestrol - oral tablet - 5mg
diethylstilbestrol 5mg tablets
p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - diethylstilbestrol - film-coated tablet - diethylstilbestrol 5 mg - endocrine therapy
diethylstilbestrol tablets 1mg
p & d pharmaceuticals limited - diethylstilbestrol - tablet - diethylstilbestrol 1 mg - endocrine therapy
diethylstilbestrol 5mg tablets
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - diethylstilbestrol - film-coated tablet - diethylstilbestrol 5 mg - endocrine therapy
diethyltoluamide
david gray & co. pty limited - diethyltoluamide - unknown - diethyltoluamide insect repellent active 0.0 - active constituent
diethyltoluamide
virbac (australia) pty ltd - diethyltoluamide - unknown - diethyltoluamide insect repellent active 0.0 - active constituent
tepanil- diethylpropion hydrochloride tablet, extended release
qualitest products, inc. - diethylpropion hydrochloride (unii: 19v2pl39ng) (diethylpropion - unii:q94yyu22b8) - tablet, extended release - 75 mg - diethylpropion hydrochloride tablets are indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regiment of weight reduction based on caloric restriction. the usefulness of agents of this class should be measured against possible risk factors inherent in their use such as those described (see clinical pharmacology). diethylpropion hydrochloride should not be used in patients with advanced arteriosclerosis, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma, severe hypertension, a history of drug abuse, or those in an agitated state (see precautions). diethylpropion hydrochloride should not be given during, or within fourteen days following, the administration of monoamine oxidase inhibitors; hypertensive crises may result. diethylpropion is a schedule iv controlled substance. diethylpropion has some chemical and pharmacologic similarities to the amphetamines and other related stimulant drugs that have been extensively abused.
diethylpropion hcl controlled-release- diethylpropion hydrochloride tablet
rebel distributors corp - diethylpropion hydrochloride (unii: 19v2pl39ng) (diethylpropion - unii:q94yyu22b8) - diethylpropion hydrochloride is indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (bmi) of 30 kg/m2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. below is a chart of bmi based on various heights and weights. bmi is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters. the usefulness of agents of this class (see clinical pharmacology ) should be measured against possible risk factors inherent in their use such as those described below. diethylpropion hydrochloride is indicated for use as monotherapy only. pulmonary hypertension, advanced arteriosclerosis, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma, severe h
diethylpropion hydrochloride tablet
unit dose services - diethylpropion hydrochloride (unii: 19v2pl39ng) (diethylpropion - unii:q94yyu22b8) - diethylpropion hydrochloride is indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (bmi) of 30 kg/m or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. below is a chart of bmi based on various heights and weights. bmi is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters. 2 the usefulness of agents of this class (see ) should be measured against possible risk factors inherent in their use such as those described below. diethylpropion hydrochloride is indicated for use as monotherapy only. clinical pharmacology pulmonary hypertension, advanced arteriosclerosis, hyperthyroidism, known hypersensitivity or idiosy
diethylpropion hcl controlled-release- diethylpropion hydrochloride tablet
blenheim pharmacal, inc. - diethylpropion hydrochloride (unii: 19v2pl39ng) (diethylpropion - unii:q94yyu22b8) - diethylpropion hydrochloride is indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (bmi) of 30 kg/m 2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. below is a chart of bmi based on various heights and weights. bmi is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters. the usefulness of agents of this class (see clinical pharmacology ) should be measured against possible risk factors inherent in their use such as those described below. diethylpropion hydrochloride is indicated for use as monotherapy only. pulmonary hypertension, advanced arteriosclerosis, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic